Yasser A. Hassan - Search Results

Year	Number of Results
2018	1
2020	2
2021	1
2022	2
2023	4
2024	3

1

New repurposed rolapitant in nanovesicular systems for lung cancer treatment: Development, in-vitro assessment and in-vivo biodistribution study.

Kabil MF, Nasr M, Ibrahim IT, Hassan YA, El-Sherbiny IM. Kabil MF, et al. Among authors: hassan ya. Eur J Pharm Sci. 2022 Apr 1;171:106119. doi: 10.1016/j.ejps.2022.106119. Epub 2022 Jan 6. Eur J Pharm Sci. 2022. PMID: 34998905 Free article.

2

Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon Cancer.

El-Shenawy AA, Elsayed MMA, Atwa GMK, Abourehab MAS, Mohamed MS, Ghoneim MM, Mahmoud RA, Sabry SA, Anwar W, El-Sherbiny M, Hassan YA, Belal A, Ramadan AEH. El-Shenawy AA, et al. Among authors: hassan ya. Pharmaceutics. 2023 Feb 17;15(2):680. doi: 10.3390/pharmaceutics15020680. Pharmaceutics. 2023. PMID: 36840004 Free PMC article.

3

Tolmetin Sodium Fast Dissolving Tablets for Rheumatoid Arthritis Treatment: Preparation and Optimization Using Box-Behnken Design and Response Surface Methodology.

Elsayed MMA, Aboelez MO, Elsadek BEM, Sarhan HA, Khaled KA, Belal A, Khames A, Hassan YA, Abdel-Rheem AA, Elkaeed EB, Raafat M, Elsadek MEM. Elsayed MMA, et al. Among authors: hassan ya. Pharmaceutics. 2022 Apr 18;14(4):880. doi: 10.3390/pharmaceutics14040880. Pharmaceutics. 2022. PMID: 35456714 Free PMC article.

4

Alginate-chitosan-microencapsulated tyrosols/oleuropein-rich olive mill waste extract for lipopolysaccharide-induced skin fibroblast inflammation treatment.

Hendawy OM, Al-Sanea MM, Mohammed Elbargisy R, Ur Rahman H, Hassan YA, Elshaarawy RFM, Khedr AIM. Hendawy OM, et al. Among authors: hassan ya. Int J Pharm. 2023 Aug 25;643:123260. doi: 10.1016/j.ijpharm.2023.123260. Epub 2023 Jul 20. Int J Pharm. 2023. PMID: 37481097

5

Radioiodination and in vivo assessment of the potential of newly synthesized pyrrolizine-5-carboxamides derivative in tumor model.

Mahmoud AF, Aboumanei MH, Abdelhalim S, Hassan YA, Ibrahim IT. Mahmoud AF, et al. Among authors: hassan ya. Appl Radiat Isot. 2020 Dec;166:109369. doi: 10.1016/j.apradiso.2020.109369. Epub 2020 Aug 8. Appl Radiat Isot. 2020. PMID: 32828009

6

Comparison of the ameliorative roles of crab chitosan nanoparticles and mesenchymal stem cells against cisplatin-triggered nephrotoxicity.

Shati AA, Alkabli J, Alfaifi MY, Elbehairi SEI, Elshaarawy RFM, Serag WM, Hassan YA. Shati AA, et al. Among authors: hassan ya. Int J Biol Macromol. 2023 Jul 1;242(Pt 4):124985. doi: 10.1016/j.ijbiomac.2023.124985. Epub 2023 May 23. Int J Biol Macromol. 2023. PMID: 37230447

7

Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization.

M Tawfeek H, Hassan YA, Aldawsari MF, H Fayed M. M Tawfeek H, et al. Among authors: hassan ya. Pharmaceuticals (Basel). 2020 Dec 5;13(12):446. doi: 10.3390/ph13120446. Pharmaceuticals (Basel). 2020. PMID: 33291402 Free PMC article.

8

Co-delivery of imidazolium Zn(II)salen and Origanum Syriacum essential oil by shrimp chitosan nanoparticles for antimicrobial applications.

Hassan YA, Khedr AIM, Alkabli J, Elshaarawy RFM, Nasr AM. Hassan YA, et al. Carbohydr Polym. 2021 May 15;260:117834. doi: 10.1016/j.carbpol.2021.117834. Epub 2021 Feb 18. Carbohydr Polym. 2021. PMID: 33712171

9

Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.

Shazly GA, Alshehri S, Ibrahim MA, Tawfeek HM, Razik JA, Hassan YA, Shakeel F. Shazly GA, et al. Among authors: hassan ya. AAPS PharmSciTech. 2018 May;19(4):1712-1719. doi: 10.1208/s12249-018-0987-2. Epub 2018 Mar 12. AAPS PharmSciTech. 2018. PMID: 29532427

10

Development of oral formulation of Lepidium seeds significantly decreases the high blood glucose levels in diabetic rats: in vitro formulation and in vivo antidiabetic performance.

Aldosari BN, Abdellatif AAH, Almurshedi AS, Alfagih IM, AlQuadeib BT, Abbas AYA, Hassan YA, Abdelfattah A, Tawfeek HM. Aldosari BN, et al. Among authors: hassan ya. Drug Dev Ind Pharm. 2024 Feb;50(2):112-123. doi: 10.1080/03639045.2023.2300649. Epub 2024 Jan 24. Drug Dev Ind Pharm. 2024. PMID: 38156891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year